z-logo
open-access-imgOpen Access
Chemotherapy of Tuberculosis
Author(s) -
C. V. Deliwala,
K. Ganapathi,
S. Rajagopalan
Publication year - 1949
Publication title -
nature
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 15.993
H-Index - 1226
eISSN - 1476-4687
pISSN - 0028-0836
DOI - 10.1038/163698a0
Subject(s) - tuberculosis , chemotherapy , medicine , oncology , pathology
Summary  The highly favourable first reports about the antibacterial merits of 5∶5′-dihalogenated salicils and the essentially sulphonamide-like nature of their action on bacteria, led to an improved method of preparation of 5∶5′-dichlorosalicil or “chlorosalicil” for ascertaining its usefulness in human tuberculosis. The ineffectiveness of chlorosalicil onP. pestis in vivo directed attention to the synthesis of a series of biologically interesting heterocyclic ring-systems, particularly the imidazole and pyrazine types, starting with chlorosalicil, benzil, 2∶2′-dichlorobenzil, anisil, diacetyl andorthoquinones, regarded as cyclic α-diketones. A total of twenty-eight heterocyclic compounds have been synthesised in this connection. Synthesis of these furnished interesting information regarding the chemistry of imidazoles. A few representative heterocyclics, now prepared, have been subjected to examination for efficacyin vivo againstP. pestis, which definitely demonstrated reduction of the original toxicity for infected mice of the initial α-diketones following heterocyclic synthesis from the ketones. However these failed to exhibit any curative action. The failure in experimental plague of the compounds studied has not yet been correlated with their possible anti-mycobacterial activities.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom